Literature DB >> 3416829

Neuropeptide Y (NPY): a possible role in the initiation of puberty.

S W Sutton1, N Mitsugi, P M Plotsky, D K Sarkar.   

Abstract

NPY modulates the rat hypothalamic-pituitary-gonadal axis at both the adenohypophysial and central levels. Previously published studies have consistently shown elevations of GnRH content in the preoptic area (POA) and hypothalamus starting with the appearance of GnRH immunoreactivity around fetal day 12-14 until stabilization around the time of puberty. In the present studies, irNPY content of male and female rat hypothalami and POA was examined during days 0 to 36 of postnatal development. Hypothalamic irNPY content rose steadily from 4.54 +/- 0.19 ng/fragment (males) and 2.72 +/- 0.55 ng/fragment (females) at birth to 34.14 +/- 3.94 ng/fragment (males) and 46.79 +/- 6.16 ng/fragment (females) at day 36, corresponding approximately to the time of vaginal opening. A similar elevation of irNPY content was observed in the POA. At day 0, POA content was 1.91 +/- 0.18 ng/fragment (males) and 2.02 +/- 0.25 ng/fragment (females) and progressively increased to 42.26 +/- 3.94 ng/fragment and 41.33 +/- 3.72 ng/fragment by postnatal day 36. In subsequent investigations, hypophysial-portal and peripheral plasma irNPY was determined around the time of vaginal opening, revealing a surge in portal levels of irNPY which preceded the prepubertal LH surge. The progressive postnatal increase in hypothalamic and POA irNPY content culminating in a prepubertal surge of irNPY secretion into the hypophysial-portal circulation suggests involvement of this neuropeptide in reproductive development and the onset of puberty.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3416829     DOI: 10.1210/endo-123-4-2152

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  8 in total

Review 1.  The Emerging Role of Chromatin Remodeling Factors in Female Pubertal Development.

Authors:  Carlos Francisco Aylwin; Katinka Vigh-Conrad; Alejandro Lomniczi
Journal:  Neuroendocrinology       Date:  2019-02-07       Impact factor: 4.914

2.  Facilitatory role of neuropeptide Y on the onset of puberty: effect of immunoneutralization of neuropeptide Y on the release of luteinizing hormone and luteinizing-hormone-releasing hormone.

Authors:  S Minami; S A Frautschy; P M Plotsky; S W Sutton; D K Sarkar
Journal:  Neuroendocrinology       Date:  1990-07       Impact factor: 4.914

3.  Orexin A induces GnRH gene expression and secretion from GT1-7 hypothalamic GnRH neurons.

Authors:  Ravid Sasson; Robert K Dearth; Rachel S White; Patrick E Chappell; Pamela L Mellon
Journal:  Neuroendocrinology       Date:  2006-12-28       Impact factor: 4.914

4.  Gonadotropin-releasing hormone and NMDA receptor gene expression and colocalization change during puberty in female rats.

Authors:  A C Gore; T J Wu; J J Rosenberg; J L Roberts
Journal:  J Neurosci       Date:  1996-09-01       Impact factor: 6.167

5.  Effects of electroacupuncture on the expression of hypothalamic neuropeptide Y and ghrelin in pubertal rats with polycystic ovary syndrome.

Authors:  Yang Li; Wang Zhi; Dong Haoxu; Wang Qing; Cheng Ling; Yi Ping; Huang Dongmei
Journal:  PLoS One       Date:  2022-06-15       Impact factor: 3.752

Review 6.  Development of gonadotropin-releasing hormone (GnRH) neuron regulation in the female rat.

Authors:  D Becú-Villalobos; C Libertun
Journal:  Cell Mol Neurobiol       Date:  1995-02       Impact factor: 5.046

7.  Immunocytochemical and histochemical analyses of gonadotrophin releasing hormone, tyrosine hydroxylase, and cytochrome oxidase reactivity within the hypothalamus of chicks showing early sexual maturation.

Authors:  G S Fraley; W J Kuenzel
Journal:  Histochemistry       Date:  1993-03

8.  Prepubertal increases in gonadotropin-releasing hormone mRNA, gonadotropin-releasing hormone precursor, and subsequent maturation of precursor processing in male rats.

Authors:  C M Dutlow; J Rachman; T W Jacobs; R P Millar
Journal:  J Clin Invest       Date:  1992-12       Impact factor: 14.808

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.